AINewsnow

Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

This story is from 2026-09-07. It is preserved in the archive; the latest stories are on the live feed.

Blood samples from a small lung-disease trial have been run through six independently built ageing clocks, and all six returned the same answer: the patients on the drug looked biologically younger than the patients on placebo. “More lifetimes than humanity lost in all the wars ever fought. If you…

Read the full story at The Next Web ↗

Timeline · 1 report

  1. 2026-09-07 12:13 · The Next Web
    Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

More stories

  1. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  2. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  3. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  4. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  5. Meet the Data Agent in ChatGPT Work — OpenAI YouTube
  6. AI hallucination of Chinese nuclear components almost led to US military attack — Ars Technica AI
  7. TypeSafe AI Releases Jev: A System One Model That Returns Typed, Calibrated Decisions Instead of Text — MarkTechPost
  8. AI's role in building AI surging? Anthropic says Claude now leads 26% of its R&D — Mint AI

Get the daily brief of stories like this at 6:30 every morning →